Document is current
Any future updates will be listed below
-
Authors
Kalantar-Zadeh, Kamyar
Ficociello, Linda H.
Zhou, Meijiao
Anger, Michael S.
-
Funding
Funding for this research was provided by:
Fresenius Medical Care
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 10 June 2024
First Online: 17 June 2024
Declarations
:
: This study was reviewed by the New England Independent Review Board (NEIRB)/WCG IRB and determined to be exempted under the common rule and applicable guidance. Due to the anonymous and purely observational nature of the study, the need for informed consent was waived by an independent institutional review board (New England Independent Review Board (NEIRB)/WCG IRB, Needham, MA, USA; Work Order 17-1396220-1).
: Not applicable.
: LHF, MZ, and MSA are employees of Fresenius Medical Care Global Medical Office. LHF and MSA hold ownership interests in Fresenius Medical Care. KK-Z has received honoraria and/or support from Abbott, Abbvie, ACI Clinical (Cara Therapeutics), Akebia, Alexion, Amgen, Ardelyx, ASN (American Society of Nephrology), Astra-Zeneca, Aveo, BBraun, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, GSK, Haymarket Media, Hofstra Medical School, IFKF (International Federation of Kidney Foundations), ISH (International Society of Hemodialysis), International Society of Renal Nutrition & Metabolism (ISRNM), JSDT (Japanese Society of Dialysis Therapy), Hospira, Kabi, Keryx, Kissei, Novartis, NovoNordisk, OPKO, NIH (National Institutes of Health), NKF (National Kidney Foundations), Pfizer, Regulus, Relypsa, Resverlogix, Dr. Schaer, Sandoz, Sanofi, Shire, VA (Veterans Affairs), Takeda, Vifor, UpToDate, ZS-Pharma.
